L-Thyroxine-13C9,15N
- ₹0
- Product name: L-Thyroxine-13C9,15N
- CAS: 1431868-11-9
- MF: C15H11I4NO4
- MW: 786.96002
- EINECS:
- MDL Number:
- Synonyms:L-Thyroxine-13C9,15N;Levothyroxine-13C9-15N;Thyroxine Carboxy,α,β,1,2,3,4,5,6-13C9,15N;O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-L-tyrosine-carboxy,α,β,1,2,3,4,5,6-13C9-15N
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|
Properties
storage temp. :Store at -20°C
solubility :DMF: 0.14 mg/ml; DMSO: 2.5 mg/ml; DMSO:PBS (pH 7.2) (1:1): 0.50 mg/ml
form :A solid
solubility :DMF: 0.14 mg/ml; DMSO: 2.5 mg/ml; DMSO:PBS (pH 7.2) (1:1): 0.50 mg/ml
form :A solid
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|
Description
L-Thyroxine-13C9,15N is intended for use as an internal standard for the quantification of L-thyroxine by GC- or LC-MS. L-Thyroxine is a synthetic form of the thyroid hormone thyroxine. In vivo, L-thyroxine (0.9 and 2.7 μg) inhibits synthesis and release of thyrotropin induced by thyrotropin-releasing hormone from the anterior pituitary in mice. It also reverses decreases in levels of circulating thymic serum factor (FTS) and the number of T rosette-forming cells in an old age-induced mouse model of hypothyroidism. Formulations containing L-thyroxine have been used in the treatment of hypothyroidism.More related product prices
3,5-DIIODOTHYROACETIC ACID Levothyroxine EP Impurity B Levothyroxine Impurity 16 1027-28-7 3,5-Diiodo-DL-tyrosine thyroxine glucuronide 3,5-Diiodo-L-thyronine REVERSE T3 67-30-1 6893-02-3 51-24-1 Sodium levothyroxine N-Acetyl-L-thyroxine Ethyl Ester 3,5,3',5'-Tetraiodo Thyroaldehyde N-Acetyl L-ThyroxineRelated product price
- 1027-28-7
₹3300 - 3,5-Diiodo-L-thyronine
₹3000-78156.5 - REVERSE T3
₹13898.5